<span item_type="fundamental" item_id="4159cbe73d491fd35f7ed3a270b8c898" counter_id="ST/US/CBGGF" env="prod"></span><span item_type="announcement" item_id="582814281049249665" env="prod"></span><p>Revenue: As of FY2025 Q3, the actual value is USD 0.</p><p>EPS: As of FY2025 Q3, the actual value is USD -0.21.</p><p>EBIT: As of FY2025 Q3, the actual value is USD -292.67 K.</p><p></p><h3>Segment Revenue</h3><ul><li><strong>General and Administrative Expenses</strong>: For the three months ended September 30, 2025, expenses were $235,955, compared to $749,158 for the same period in 2024. For the nine months ended September 30, 2025, expenses were $763,088, compared to $1,882,579 in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1845149/000121390025111059/ea0265577-10q_chain1.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li><strong>Net Loss</strong>: For the three months ended September 30, 2025, the net loss was $1,304,431, compared to a net income of $326,476 for the same period in 2024. For the nine months ended September 30, 2025, the net loss was $1,662,278, compared to a net loss of $1,359,371 in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1845149/000121390025111059/ea0265577-10q_chain1.htm"></span></li></ul><h3>Cash Flow</h3><ul><li><strong>Net Cash Used in Operating Activities</strong>: For the nine months ended September 30, 2025, net cash used was $410,927, compared to $626,508 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1845149/000121390025111059/ea0265577-10q_chain1.htm"></span></li></ul><h3>Unique Metrics</h3><ul><li><strong>Income from Investments Held in Trust Account</strong>: For the three months ended September 30, 2025, income was $56,719, compared to $147,634 for the same period in 2024. For the nine months ended September 30, 2025, income was $168,010, compared to $636,883 in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1845149/000121390025111059/ea0265577-10q_chain1.htm"></span></li></ul><h3>Future Outlook and Strategy</h3><ul><li><strong>Core Business Focus</strong>: The company has until November 15, 2026, to consummate an initial Business Combination. If not completed by this date, the company must cease operations, redeem public shares, and liquidate.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1845149/000121390025111059/ea0265577-10q_chain1.htm"></span></li><li><strong>Non-Core Business</strong>: The company is exploring a Business Combination with Phytanix Bio, which involves merging with CB Merger Sub and Phytanix Merger Sub, with the company and Phytanix becoming wholly owned subsidiaries of HoldCo.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1845149/000121390025111059/ea0265577-10q_chain1.htm"></span></li></ul>

CHAIN BRIDGE I UNIT 1 CL A & 1/2 RED WT EXP(15/11/2024) | 10-Q: FY2025 Q3 Revenue: USD 0